CARGO Therapeutics, Inc. Common StockCRGXNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank0
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 2Y Ago
-6.9x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q2 2025 | -75.49% |
| Q1 2025 | -22.45% |
| Q4 2024 | 9.94% |
| Q3 2024 | -4.07% |
| Q2 2024 | 22.80% |
| Q1 2024 | 12.69% |
| Q4 2023 | 21.74% |
| Q3 2023 | 59.62% |
| Q2 2023 | 10.88% |
| Q1 2023 | 36.08% |
| Q4 2022 | 9.00% |
| Q3 2022 | 0.00% |